Nestlé scientists have identified a nutrient blend of components found in breast milk which is essential for brain health and created a new product utilising this blend.
Nestlé has scored a point against competitor Reckitt Benckiser by inducing it to drop claims for the probiotic and DHA content of one of its infant formulas.
NZMP, the global dairy ingredients brand of Fonterra, has announced a European patent has been granted allowing NZMP customers the ability to position their products as beneficial for cognitive development.
Jennewein Biotechnologie GmbH, a German company involved in the research and manufacture of human milk oligosaccharides (HMO), and Inner Mongolia Yili Industrial Group (Yili Group), China’s leading dairy company, have signed a Memorandum of Understanding...
Infant formula products developed specifically for babies with certain disorders are “often the best, and sometimes the only option,” Japanese dairy giant Meiji has claimed.
In the midst of an investigation into the pricing practices employed by it and other infant formula manufacturers in China, Biostime has admitted that the terms of its agreements with distributors “may” have broken anti-trust laws.
Premature infants fed formula are more likely to develop necrotising enterocolitis (NEC) - a severe, often fatal intestinal condition – than those who are breast-fed, a US study has found.
Arla Foods has signed a financing and supply agreement with signficant pediatric nutrition and baby care product producer Biostime International Holdings to supply the Hong Kong-listed company with infant formula.